Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth

AIDS

Volumn 20, Issue 18, 2006, Pages 2345-2353

  Szyld, Edgardo G ^a,h   Warley, Eduardo M ^a   Freimanis, Laura ^f   Gonin, René ^f   Cahn, Pedro E ^b   Calvet, Guilherme A ^c   Duarte, Geraldo ^d   Melo, Victor H ^e   Read, Jennifer S ^g  

^a Hospital Diego Paroissien   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f WESTAT   (United States)

^g EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^h NONE   (Argentina)

Author keywords

HAART; HIV 1; Low birth weight; Pregnancy; Preterm

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CENTRAL AMERICA; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG EFFECT; DRUG USE; FEMALE; GESTATIONAL AGE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOUTH AND CENTRAL AMERICA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ARGENTINA; BAHAMAS; BRAZIL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MEXICO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS;

EID: 33751255378     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000253362.01696.9d     Document Type: Article

References (43)

1. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40:458-465.
2. Joao EC, Cruz ML, Menezes JA, Matos HJ, Calvet GA, d'Ippolito MM, et al. Vertical transmission of HIV in Rio de Janeiro, Brazil. AIDS 2003; 17:1853-1855.
3. Gobierno de Buenos Aires, Secretaria de Salud. Recomendaciones para la prevencion de la transmision vertical del VIH. El tratamiento de la infeccion en mujeres embarazadas y el asesoramiento sobre proceacion y anticoncepcion en parejas seropositivas o serodiscordantes. Actualizacion. Buenos Aires: Secretaria de Salud; 2004:11-15. Accessed 13 January 2006: http://www. buenosaires.gov.ar/areas/salud/sida/publicaciones/ recomendaciones_transmision_vertical.pdf;
4. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29:484-494.
5. Nogueira SA, Abreu T, Oliveira R, Araujo L, Costa T, Andrade M, et al. Successful prevention of HIV transmission from mother to infant in Brazil using a multidisciplinary team approach. Braz J Infect Dis 2001; 5:78-86.
6. Chersich MF, Gray GE. Progress and emerging challenges in preventing mother-to-child transmission. Curr Infect Dis Rep 2005; 7:393-400.
7. Taha TET, Dallabetta GA, Canner JK, Chiphangwi JD, Liomba G, Hoover DR, et al. The effect of human immunodeficiency virus infection on birthweight and infant and child mortality in urban Malawi. Int J Epidemiol 1995; 24:1022-1029.
8. Ellis J, Williams H, Graves W, Lindsay MK. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol 2002; 186:903-906.
9. Leroy V, Ladner J, Nyiraziraje, de Clercq A, Bazubagira A, van de Perre P, et al. Effect of HIV-1 infection on pregnancy outcome in women in Kigali, Rwanda, 1992-1994. AIDS 1998; 12:643-650.
10. Markson LE, Turner BJ, Houchens R, Silverman NS, Cosler L, Takyi BK. Association of maternal HIV infection with low birth weight. J Acquir Immun Defic Syndr Hum Retrovirol 1996; 13:227-234.
11. Temmerman M, Plummer FA, Mirza NB, Ndinya-Achola JO, Wamola IA, Nagelkerke N, et al. Infection with HIV as a risk factor for adverse obstetrical outcome. AIDS 1990; 4:1087-1093.
12. Mwanyumba F, Claeys P, Gaillard P, Verhofstede C, Chohan V, Mandaliya K, et al. Correlation between maternal and infant HIV infection and low birth weight: a study in Mombasa, Kenya. J Obstet Gynaecol 2001; 21:27-31.
13. Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr 2001; 74:814-826.
14. Lambert JS, Watts DH, Mofenson L, Stiehm ER, Harris DR, Bethel J, et al. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team. AIDS 2000; 14:1389-1399.
15. Thorne C, Patel D, Newell ML. Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe. AIDS 2004; 18:2337-2339.
16. Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 1998; 12:F241-F247.
17. European Collaborative Study; Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000; 14:2913-2920.
18. Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002; 346:1863-1870.
19. Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, et al. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 2005; 38:449-473.
20. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or still-birth? J Infect Dis 2006; 193:1195-1201.
21. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32:380-387.
22. Wimalasundera RC, Larbalestier N, Smith JH, de Ruiter A, McG Thom SA, Hughes AD, et al. Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 2002; 360:1152-1154.
23. European Collaborative Study. Pregnancy-related chanes in the longer-term management of HIV-infected women in Europe. Eur J Obstet Gynecol Reprod Biol 2003; 111:3-8.
24. Suy A, Martinez E, Coll O, Lonca M, Palacio M, de Lazzari E, et al. Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy. AIDS 2006; 20:59-66.
25. Xiao R, Sorensen TK, Williams MA, Luthy DA. Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13:157-162.
26. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? Br J Obstet Gynaecol 2004; 111:298-302.
27. Attico NB, Meyer DJ, Bodin HJ, Dickman DS. Gestational age assessment. Am Fam Physician 1990; 41:553-560.
28. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119:417-423.
29. Dubowitz LM, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970; 77:1-10.
30. Capurro H, Konichezky S, Fonseca D, Caldeyro-Barcia R. A simplified method for diagnosis of gestational age in the newborn infant. J Pediatr 1978; 93:120-122.
31. Centers for Disease Control 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41:1-19.
32. Ministerio de Salud y Ambiente de la Nación, Dirección Nacional de Salud Materno Infantil, Programa Materno Infantil, Provincia de Buenos Aires y la Dirección de Información de la Provincia de Neuquén. [Ministry of Health and Environment of the Nation, National Directorate of Maternal and Infant Health, Maternal and Infant Program of the Buenos Aires Province and the Directorate of Information of the Province of Neuquén.] Programa Nutri Desarrollado en EpiInfo. [Nutri Program, Developed in EpiInfo.] Accessed 16 February 2006: http://www.msal.gov.ar/htm/ Site/promin/UCMISALUD/utilidades/util.htm.
33. Division of AIDS, National Institute of Allergy and Infectious Diseases. Table for Grading the Severity of Adult and Pediatric Adverse Events, version 1.0. Maryland, MD: National Institute of Allergy and Infectious Diseases; 2004. Accessed 16 February 2006: http://rcc.tech-res-intl.com.
34. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 1951; 38:141-149.
35. Read JS, Burchett S, Shapiro D, Pollack H, McNamara J, Ortiz-Pujols S, et al. Low birth weight and preterm birth among infants of HIV-infected mothers according to maternal receipt of antiretroviral drug(s) during pregnancy: PACTG 367. 41st Annual Meeting of the Infectious Diseases Society of America. San Diego, October 2003 [abstract 677].
36. Althabe F, Carroli G, Led R, Belizán JM, Althabe O. El parto pretérmino: detección de riesgos y tratamiento preventives. Rev Panam Salud Pública 1999; 5:373-385.
37. Hortal BL, Victoria CG, Menezes AM, Halpern R, Barros FC. Low birthweight, preterm birth and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol 1997; 2:140-151.
38. Barros FC, Victora CG, Barros AJ, Santos IS, Albernaez E, Matijasevich A, et al. The challenge of reducing neonatal mortality in middle-income countries: findings for three Brazilian birth cohorts in 1982, 1983 and 2004. Lancet 2005; 365: 847-854.
39. Federación Argentina de Sociedades de Ginecología y Obstetrica. Consenso Argentino: uso de corticosteroides para la prevención de síndrome de distress respiratorio. May 22, 2006. Accessed 23 May 2006: http://www.fasgo.org.ar/consensos/info/corticosteroides. htm.
40. Canto-de Cetina T, Polanco-Reyes L, Fernández-González V, Ruiz-García S. Infección por Chlamydia trachomatis en usuarias de dos clínicas de planificación familiar. Salud Publ Méx 2003; 45 (Suppl 5):S657-S661.
41. Quiroga Cantú M, García R, Reyes de los Santos EA. Morbimortalidad perinatal. Bol méd Hosp Infantil de México 1979; 36:871-884.
42. UNICEF. Low Birthweight: Country, Regional and Global Estimates, Table 3: UNICEF/WHO Estimates of the Incidence of Low Birthweight, 2000. New York: United Nations Children's Fund, Strategic Information Unit, Division of Policy and Planning; 2004:10-18.
43. Read J, Losso M, Pinto J, Joao E, Duarte G, Chang D, et al. A prospective cohort study of HIV-1-infected pregnant women and their infants in Latin America and the Caribbean: The NICHD International Site Development Initiative Perinatal Study. 12th Conference on Retroviruses and Opportunistic Infections. Boston, February 2005 [abstract 790].